Blood test breakthrough for tracking Muscle-Wasting diseases?
NCT ID NCT07415837
Summary
This study aims to see if a specific molecule in the blood, called miR-1, can be used as a marker to track the progression of muscle-wasting diseases. Researchers will compare miR-1 levels in people with Duchenne/Becker muscular dystrophy, myotonic dystrophy, and congenital myopathies against healthy volunteers. The goal is to understand if this molecule can reliably show how severe a person's muscle disease is and how it changes over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Clermont-Ferrand
RECRUITINGClermont-Ferrand, France
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.